The debate raised peripheral immune targeting as promising but did not address timing considerations or reversibility of CNS changes. Determining when interventions remain effective is crucial for clinical translation and patient selection. Source: Debate session sess_SDA-2026-04-04-frontier-immunomics-e6f97b29 (Analysis: SDA-2026-04-04-frontier-immunomics-e6f97b29)
Landscape Summary: What is the therapeutic window for peripheral immune modulation to prevent CNS damage? is a 0.75 priority gap in immunology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What is the therapeutic window for peripheral immune modulation to prevent CNS damage? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: